PositoAI/ US/ Boundless Bio, Inc.

Boundless Bio, Inc.

NasdaqGS: BOLD · Healthcare

Positivity Index

#4,253 / 6,774

Global

#2,080 / 4,000

United States

Positivity Score

19,720

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

Boundless Bio, Inc. — Overview & Financial Snapshot

Boundless Bio, Inc. (NasdaqGS: BOLD) is a Healthcare company, ranked #4,253 of 6,774 companies globally and #2,080 of 4,000 in United States on PositoAI, with a Positivity Score of 19,720. Its market capitalisation is ₹532.23 Cr ($56.39M), P/E ratio is -0.9 and P/B ratio is 0.85. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

Boundless Bio, Inc., a clinical-stage oncology company, develops interrogating extrachromosomal DNA (ecDNA) directed therapies for treating patients with oncogene amplified cancers. Its lead product candidate is BBI-940, an ecDNA-directed therapeutic candidate (ecDTx) that is in Phase 1/2 clinical trial in patients with estrogen receptor positive and human epidermal growth factor receptor 2 negative breast cancer, as well as patients with triple-negative breast cancer luminal androgen receptor subtype. The company was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. Boundless Bio, Inc. was incorporated in 2018 and is headquartered in San Diego, California.

P/B Ratio 0.85

P/E Ratio -0.9

D/E Ratio 0.50

ROE -67.86%

Owes vs Owns ? 0.11× Low $0.11 owed for every $1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹-269.01$-2.85

Forward EPS ₹-92.50$-0.98

Beta 0.47

Market Cap ₹532.23 Cr$56.39M

What these numbers mean →

What does Boundless Bio, Inc. do?

What is Boundless Bio, Inc.'s P/E and P/B ratio?

Boundless Bio, Inc. has a P/E ratio of -0.9 and a P/B ratio of 0.85.

What is Boundless Bio, Inc.'s debt-to-equity ratio?

Boundless Bio, Inc. has a debt-to-equity ratio of 0.50.

How much does Boundless Bio, Inc. owe compared with what it owns?

Boundless Bio, Inc. owes $0.11 for every $1 it owns (balance sheet Jun 2026), which is low.

What is Boundless Bio, Inc.'s Positivity rank?

Boundless Bio, Inc. is ranked #4,253 of 6,774 companies globally and #2,080 of 4,000 in United States on PositoAI, with a Positivity Score of 19,720.

Does Boundless Bio, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Boundless Bio, Inc..

Where can I read the latest news about Boundless Bio, Inc.?

Recent headlines about Boundless Bio, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Boundless Bio, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Boundless Bio, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.